수닛 탈라파트라 박사의 업무는 제약, 진단, 농업, 식품 및 영양, 의료 기기 등 다양한 기술 분야의 고객사들이 필요로 하는 지적 재산권 관련 업무에 중점을 두고 있습니다. 또한 네덜란드에서 거주한 경험이 있으며 유럽 대륙을 자주 방문하는 등 미국과 연계된 유럽 기업들에 대한 독특한 시각을 보유하고 있습니다. 그는 본 로펌의 화학, 생명공학 및 제약 부문, 사모펀드 및 벤처 캐피털 부문, 그리고 헬스케어 및 생명과학 부문의 파트너입니다.
In addition to patent counseling and prosecution matters, Sunit has argued several cases before the United States Patent Trial and Appeal Board, notably orchestrating a successful defense in the “1st-Ever” Pharma AIA Ruling (Amneal Pharma Inc v. Supernus Pharma Inc.). Some of his exemplary patent cases include Chatterjee v. Tabor (interference proceeding re DNA polymerase); Keygene NV v. Floragenex, Inc. (patent infringement action); and Biota Scientific Ltd. v. Kappos (appeal of USPTO decision re obviousness of pharmaceutical formulation).
수상 및 표창
- Recognized in IAM Patent 1000 – The World’s Leading Patent Practitioners (2024)
프레젠테이션 및 출판물
- “General Counsel Speak: Building a Forward-Thinking IP Strategy,” Foley’s Annual IP Conference (October 2022)
- “Perspectives on the New Normal,” Foley’s Annual IP Conference (October 2021)
- “Patenting Strategies: The Counsel (Corporate and Private),” FCBA Global Outreach Series (October 2016)
- “IP Management: Getting It Right in Both Europe and the US,” Innovation for Health Conference (February 2014)
- “Legal Issues Facing Health Companies in the US Market,” Health & Technology Conference (September 2013)
- “Hindsight is 20/20: Entrepreneurs Share Viewpoints on What They Wish They’d Known,” Nanotech Commercialization Conference (April 2013)
- “Intellectual Property,” Wharton Business Law Conference (February 2013)
- “Intellectual Property Life Cycle Management—Thoughts to Consider in Strategic Patent Protection,” American Chemical Society (August 2012)
- “Risk vs Value: The Impact of Nanotechnology Environmental Health Safety (EHS) on Business Decisions,” Nanotech Commercialization Conference (April 2012)
- “What’s ‘natural’ about natural resources? Implications for your IP,” American Chemical Society (March 2011)
- Talapatra S, Bent S, The Art of Negotiating with U.S. Patent Examiners, A.I.P.P.I. 56(2), (2011)
- “Negotiating a patent: the art of Examiner interviews,” American Chemical Society (August 2010)
- Talapatra S, Thompson CB, et al., Elongation Factor-1 alpha Is a Selective Regulator of Growth Factor Withdrawal and ER Stress- induced Apoptosis, Cell Death Differ., 9(8), 2002, 856-61
- Karnauskas R, Talapatra S, and Rudin C, et al., Bcl-xL and Akt Cooperate to Promote Leukemogenesis In Vivo, Oncogene, 22(5), 2003, 688-98
사고 리더십
Sunit has authored several legal and scientific publications and is frequently quoted in FDA Week and Inside Health Policy. He also regularly lectures on patent matters, most recently at the 2016 FCBA Global Outreach Series (Paris).
제21회 연례 IP 컨퍼런스
IAM, 2025년판 'IAM 특허 1000: 세계 최고의 특허 실무자'에서 폴리 변호사와 관할 지역을 인정받다
